Industrial-scale, genomics-based drug design and discovery

By Dean P.M.   Zanders E.D.   Bailey D.S.  

Trends in Biotechnology, Vol. 19, Iss. 8, 2001-08 ,pp. : 288-292

Elsevier

Access to resources Recommend Favorite

Full-speed mammalian genetics: in vivo target validation in the drug discovery process

By Abuin A.   Holt K.H.   Platt K.A.   Sands A.T.   Zambrowicz B.P.  

Trends in Biotechnology, Vol. 20, Iss. 1, 2002-01 ,pp. : 36-42

Elsevier

Access to resources Recommend Favorite

Glycogen Synthase Kinase-3: A Potential Target for Drug Discovery in the Treatment of Neurodegenerative Disorders

By  

Current Enzyme Inhibition, Vol. 13, Iss. 2, 2017-06 ,pp. : 107-128

Bentham Science Publishers

Access to resources Recommend Favorite

Proteomics: a technology-driven and technology-limited discovery science

By Lee K.H.  

Trends in Biotechnology, Vol. 19, Iss. 6, 2001-06 ,pp. : 217-222

Elsevier

Access to resources Recommend Favorite

Dual-purpose drug discovery

By Wagner B.K.   Clemons P.A.  

Trends in Biotechnology, Vol. 20, Iss. 12, 2002-12 ,pp. : 492-493

Elsevier

Access to resources Recommend Favorite